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Abstract
With a view to the application in oral controlled drug delivery systems (DDS), the design of new
interpolyelectrolyte complexes (IPECs) between countercharged types of Eudragit® EPO (EPO)
and Eudragit® L 100-55 (L100-55) was investigated. The formation and composition of four new
IPECs between EPO and L100-55 were established by elementary analysis. The structure of the
synthesized  IPEC  was  investigated  using  FTIR  spectroscopy  and  modulated-temperature
differential scanning calorimetry. The binding ratio of a unit molecule of EPO with L100-55 was
found to range between 1:2.75 (Z = 0.36) and 1:0.55 (Z = 1.81) while increasing the pH value
from 5.5 to 7.0. As a result of electrostatic interaction between the copolymer chains, the glass
transition temperature of the IPEC increased significantly. A large pH-sensitive swelling behavior
was observed for different structures of the IPECs. The outcome of swelling and diclofenac
sodium release from the polycomplex matrices confirm that they have great potential to be
used as a controlled DDS in specified regions of gastrointestinal tract. © 2010 Wiley-Liss, Inc.
and the American Pharmacists Association.
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